Equity
€39,395 from €312,887 in 2024
Equity fell by 87% in 1 year.
INDOLORIS
Lifetime
6 annual accounts with figures on one time axispeak €247,103 (2025)
€247,103▲ 1.1%
peak €176,508 (2025)
€176,508▲ 2.7%
peak €312,887 (2024)
€39,395▼ 87.4%
€218,746▲ 648%
Board1 name since 2020
1 director
Documentsfilings and deeds
04-05-202688 days before the deadline
2025micro format
Dividend €450,000Equity from €312,887 to €39,395Debts from €29,252 to €218,746Cash from €166,998 to €94,543
Key points
from the 2025 annual accountsTurnover
≈ €460,000 estimated
The micro format states no turnover.
Debts
€218,746 85% of the balance sheet
Suppliers 3%Taxes and wages 11%Other 87%
Liquidity
1.14 was 10.97 in 2024
Short-term debts rose from €29,252 to €218,746.
Filings
6 annual accounts since 2020
The last five annual accounts were filed 10 to 111 days before the end of the period.
Position in the sector
15.3%
Lower solvency than 82% of companies in human health. Sector median 63.1% · 21,322 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as INDOLORIS has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for INDOLORIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0745456579
Registered office moved from Koekelberg to Brussels
New registered office: Rue Hydraulique 22 à 1210 Bruxelles · Previous registered office: Avenue de la Basilique 359 bte 15, 1081 Koekelberg · General meeting of 09-05-2022 · Gazette deed
Registered office moved from Orp-Jauche to Koekelberg
New registered office: Avenue de la Basilique 359 bte 15, 1081 Koekelberg · Previous registered office: Rue de la Marne (J-J) 11, 1350 Orp-Jauche · General meeting of 14-04-2021 · Gazette deed
Incorporation
Founder: · 1,000 shares · Appointment: (director) · published on 19-03-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| INDOLORIS Saint-Josse-ten-Noode | €258,141 | €247,103 | 15.3% | - |
| CESALBE Uccle | €276,083 | €257,121 | 43.2% | - |
| Dr. D. Raymakers Lummen | €246,363 | €248,683 | 17.5% | - |
| Docteur Maxime Rousié - chirurgie plastique Ath | €274,775 | €253,591 | 40.0% | - |
| Dr. Steffi Cattoir, anesthesie Laarne | €277,771 | €260,136 | 87.2% | - |
| Dr. Barbara Hermans Waregem | €268,646 | €246,030 | 21.8% | - |
| Newell Sleep Lasne | €271,670 | €267,114 | 72.4% | - |
These companies have the same main activity as INDOLORIS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €246,000 and €278,000, founded between 2019 and 2020.
Official details
Source: KBO- Status
- Active since 17-03-2020Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.301.086.7551210 Saint-Josse-ten-Noode, since 17-03-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Annual accounts 2025
- €258,141▼ 24.6%
- Filing
- Filed on 04-05-2026, 88 days before the end of the filing period
Insights on INDOLORIS
INDOLORIS files the micro format. That format states no turnover. The gross margin rose from €88,082 in 2020 to €247,103 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about INDOLORIS
- What is the company number of INDOLORIS?
- The company number of INDOLORIS is 0745.456.579. The VAT number is the same number with BE in front: BE 0745.456.579.
- Where is INDOLORIS based?
- The registered office is at Waterkrachtstraat 22, 1210 Saint-Josse-ten-Noode.Company details
- What does INDOLORIS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of INDOLORIS?
- INDOLORIS is a private limited company (BV).
- When was INDOLORIS founded?
- INDOLORIS was founded on 17-03-2020.
- Is INDOLORIS still active?
- Yes, INDOLORIS is an active enterprise in the KBO register.
- What is the turnover of INDOLORIS?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €247,103 and 40 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
- Is INDOLORIS profitable?
- In financial year 2025, INDOLORIS made a profit of €176,508.
- Where can I find the annual accounts of INDOLORIS?
- INDOLORIS filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of INDOLORIS due?
- INDOLORIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.